Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021
HomeCLINICAL TRIALS, STUDIES, DATARadiometer: The UK Based Company Announces POCT Analyzers Help Tackle ED Overcrowding...

Radiometer: The UK Based Company Announces POCT Analyzers Help Tackle ED Overcrowding with a Faster Diagnoses

MARKET REPORTS

Global $45 Billion Endoscopy Market Insights & Forecasts to 2025

The global endoscopy market is predicted to reach US$45.28 billion in 2025, growing, at a CAGR of 7.50%, for the duration spanning 2021-2025.

Global Remote Monitoring Devices Market Research Report (2021 to 2026)

Global Remote Monitoring Devices Market size was estimated at USD 1,035.35 million in 2020, is expected to reach USD 1,170.22 million in 2021.

Research Efforts Fuel the Future of Global Obstructive Lung Disease Management Markets – ResearchAndMarkets.com

The "Global Obstructive Lung Disease Management Research Report" report has been added.

Global Electrophysiology Market (2021 to 2026) – Growth, Trends , COVID-19 Impact and Forecasts – ResearchAndMarkets.com

The Electrophysiology Market is expected to register a CAGR of 8.5% during the forecast period.

Radiometer reports that a new case study shows how point-of-care testing (POCT) involving Radiometer’s blood gas and immunoassay analyzers, has led to faster diagnoses and improved patient experience in the emergency department (ED) at Queen’s Hospital*, Romford.

The study, authored by Clare Bailey, Divisional Director of Healthcare Professionals, Cancer and Clinical Support at Barking, Havering, and Redbridge University Hospitals NHS Trust, shows how Radiometer’s POCT ABL90 FLEX PLUS blood gas analyzers and AQT90 FLEX immunoassay analyzers have enabled the ED team to manage increasing patient numbers and deliver high-quality care.

Commenting on Radiometer’s POCT analyzers, Clare Bailey said: “The benefits of the ABL90 FLEX PLUS blood gas analyzer are clear. It measures urea and blood urea nitrogen (BUN) on very small sample volumes, which helps in the stratification of patients with suspected gastrointestinal bleeding, respiratory infections, or dehydration.

Additionally, it is one of the few POCT instruments on the market that can also measure creatinine and it’s important for our department to have this capability because we can triage our patients more quickly. On top of that, we also have the AQT90 FLEX analyzer, which was a great benefit for the ED staff, because it measures, for example, troponins, D-dimer and CRP – having all three was a real game-changer for us.”

The full case study can be found at https://www.radiometer.co.uk/en-gb/knowledge-center/customer-stories/queens-hospital

*Queen’s Hospital in Romford is part of the Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT) in London, UK. Clare Bailey is the divisional director of healthcare professionals, cancer and clinical support at the BHRUT.

 

 

spot_img

DON'T MISS

AMRA Medical’s Whole-body MRI Analysis Used in FSHD Clinical Trial Research Network Study for Biomarker Development

To date, the MOVE study has used functional tests as primary outcomes, but recent studies have shown the promise of MRI for FSHD.

Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®

The publication documents two critically ill COVID-19 patients receiving a combined total of nine, six-hour Hemopurifier® treatment sessions.

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression

For people with lymphedema, movement is important from both a clinical perspective and a quality-of-life perspective. These data illustrate the Dayspring treatment’s ability to provide that essential movement while still delivering the clinical outcomes we need from compression therapy.

18-Month Below-the-Knee Data with MedAlliance’s SELUTION SLR™ Presented as Late Breaking Trial at VIVA

“We have observed minimal slow-flow phenomena, seen with other paclitaxel drug-eluting balloons.  We have observed several cases of fast wound healing with SELUTION SLR. It is easy to track and deliver. We are looking forward to gaining further clinical experience with this device,” commented Prof. Chong.

Our Sister Publication: Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy